What is PetDx?
PetDx, based in La Jolla, California, operates at the intersection of genomics and veterinary care. The company is dedicated to leveraging advanced molecular diagnostics to enhance the health and well-being of pets. By unlocking the potential of pet genomics, PetDx aims to provide veterinarians and pet owners with powerful tools for disease detection, diagnosis, and personalized treatment strategies, setting new standards in pet healthcare.
How much funding has PetDx raised?
PetDx has raised a total of $10M across 1 funding round:
Series A
$10M
Series A (2020): $10M with participation from Tech Coast Angels, Friedman BioVentures, and Petco Animal Supplies
Key Investors in PetDx
Tech Coast Angels
Tech Coast Angels is an angel investment group that provides seed funding to early-stage technology companies. Their investment in PetDx suggests a focus on innovative biotech ventures with strong market potential.
Friedman BioVentures
Friedman BioVentures is an investment firm specializing in the biotechnology and life sciences sectors. Their participation indicates a strategic interest in PetDx's advancements in molecular diagnostics for animal health.
Petco Animal Supplies
Petco Animal Supplies is a leading pet specialty retailer focused on pet wellness and care. Their investment in PetDx highlights a commitment to integrating advanced health technologies into their comprehensive pet care offerings.
What's next for PetDx?
With substantial enterprise-level backing, PetDx is strategically positioned for accelerated growth and innovation. The company is likely to invest in expanding its diagnostic capabilities, enhancing its genomic sequencing technologies, and broadening its market reach within the veterinary sector. Future endeavors may include developing new diagnostic tests for a wider range of pet conditions and forging strategic partnerships to integrate its genomic insights into mainstream pet care practices, solidifying its role as a leader in pet genomics.
See full PetDx company page
